Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Development and Validation of a UHPLC UV Method for the In-Process Control of Bosentan Monohydrate Synthesis.

Jatczak M, Sidoryk K, Kossykowska M, Łuniewski W, Zagrodzka J, Lipiec-Abramska E.

Chromatographia. 2016;79(17):1131-1141. doi: 10.1007/s10337-016-3124-y. Epub 2016 Jul 9.

2.

THE COMPARISON OF THE STABILITY INDICATING TWO HPLC METHODS AND THEIR APPLICATION FOR THE DETERMINATION OF BOSENTAN IN COATED TABLETS.

Zielińska A, Wicherkiewicz S, Łuniewski W, Sidoryk K, Pesta E, Kutner A.

Acta Pol Pharm. 2016 Jul;73(4):865-874.

PMID:
29648712
3.

Development and validation of the GC method for the quantitative determination of semi-volatile solvents in the pharmaceutical substance bosentan.

Stolarczyk EU, Groman A, Łuniewski W.

Acta Pol Pharm. 2014 Nov-Dec;71(6):1107-13. No abstract available.

4.

Synthesis, physicochemical and biological evaluation of technetium-99m labeled lapatinib as a novel potential tumor imaging agent of Her-2 positive breast cancer.

Gniazdowska E, Koźmiński P, Bańkowski K, Łuniewski W, Królicki L.

Eur J Med Chem. 2014 Nov 24;87:493-9. doi: 10.1016/j.ejmech.2014.09.080. Epub 2014 Sep 28.

PMID:
25440878
5.

Identification and physicochemical characteristics of temozolomide process-related impurities.

Łaszcz M, Kubiszewski M, Jedynak L, Kaczmarska M, Kaczmarek Ł, Łuniewski W, Gabarski K, Witkowska A, Kuziak K, Malińska M.

Molecules. 2013 Dec 11;18(12):15344-56. doi: 10.3390/molecules181215344.

6.

Stability of sample solution as a crucial point during HPLC determination of chemical purity of temozolomide drug substance.

Jedynak Ł, Puchalska M, Zezula M, Łaszcz M, Łuniewski W, Zagrodzka J.

J Pharm Biomed Anal. 2013 Sep;83:19-27. doi: 10.1016/j.jpba.2013.04.032. Epub 2013 Apr 30.

PMID:
23702563
7.

New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.

Luniewski W, Wietrzyk J, Godlewska J, Switalska M, Piskozub M, Peczynska-Czoch W, Kaczmarek L.

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6103-7. doi: 10.1016/j.bmcl.2012.08.032. Epub 2012 Aug 15.

PMID:
22944121
8.

Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.

Godlewska J, Luniewski W, Zagrodzki B, Kaczmarek L, Bielawska-Pohl A, Dus D, Wietrzyk J, Opolski A, Siwko M, Jaromin A, Jakubiak A, Kozubek A, Peczyñska-Czoch W.

Anticancer Res. 2005 Jul-Aug;25(4):2857-68.

9.

Synthesis of 6-substituted 6H-indolo[2,3-b]quinolines as novel cytotoxic agents and topoisomerase II inhibitors.

Kaczmarek L, Luniewski W, Zagrodzki B, Godlewska J, Osiadacz J, Wietrzyk J, Opolski A, Peczyńska-Czoch W.

Acta Pol Pharm. 2002 May-Jun;59(3):199-207.

Supplemental Content

Loading ...
Support Center